Delivery Order SPE2DR25D1106-SPE2DR26FJA8S
Award Date 11/24/25
Potential Completion Date 11/25/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Linzess 145 mcg capsules (30-count units) with a ceiling value of $6,272.16. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for ultimate completion by September 8, 2025, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,099.01 to AmerisourceBergen Drug Corp for the supply of Linzess 145 mcg capsules (30-count units) on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a relatively small transaction within...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Linzess 290 mcg capsules (30-count units) with a ceiling value of $43,043.86. This firm fixed-price delivery order, with an ultimate completion date of December 3, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Linzess 145 microgram capsules (30-count units) under a firm fixed-price contract with a ceiling value of $1,126.20. This non-set-aside award was executed on December 8, 2025, with an ultimate completion date of December 9, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- The Defense Logistics Agency awarded a $11,335.78 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Linzess 290 microgram capsules in quantities of 30 units. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement with a completion date of August 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,423.44 to supply Linzess 72 microgram capsules (30-count units) under a firm fixed price contract. The award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a non-competitive, non-set-aside delivery order. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,321.80 to AmerisourceBergen Drug Corp for the supply of Linzess 145 mcg capsules (30-count units) on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Linzess 145 mcg capsules (30-count) valued at $3,916.71. This non-competitive delivery order, which is firm fixed price in nature, represents a routine pharmaceutical procurement under the company's broader federal supply agreements. The order is set to be completed by August 13, 2025, with fulfillment occurring at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $4,736.39 to AmerisourceBergen Drug Corp for the supply of Linzess 145 mcg capsules (30-count units) on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Linzess 145 mcg capsules (quantity: 30 units) with a ceiling value of $1,982.96. This is a firm fixed price delivery order with an award date of September 10, 2025, and an ultimate completion date of September 11, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the...